[Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (II)]

Rev Neurol. 2018 Jul 15;67(2):50-62.
[Article in Spanish]


The Post-ECTRIMS Meeting is an emblematic event in the field of multiple sclerosis in Spain. Its chief aim is bring together the country's leading specialist neurologists to analyse the main advances made in multiple sclerosis and to review the most important topics addressed at the ECTRIMS Congress. The tenth Post-ECTRIMS Meeting was held in November 2017. Over the years this event has firmly established itself as an important meeting point where experts from all over the country get together to foster communication, establish synergies and promote and enhance research ultimately aimed at improving the prognosis and quality of life of patients with multiple sclerosis. This second part addresses the different strategies for the management of patients in advanced stages of the disease and the safety of therapy in multiple sclerosis. Likewise, attention is also drawn to the areas that require further scientific and clinical evidence. In this edition, particular importance is given to multiple sclerosis in the paediatric population and ageing in the disease. At the same time emphasis is placed on the need to conduct collaborative studies and to foster greater awareness among specialists regarding the detection and management of the comorbidities in multiple sclerosis.

Title: Revision de las novedades del Congreso ECTRIMS 2017, presentadas en la X Reunion Post-ECTRIMS (II).

La reunion Post-ECTRIMS es una reunion emblematica en el ambito de la esclerosis multiple en España, con el claro objetivo de analizar, de la mano de reconocidos neurologos especialistas nacionales, los principales avances en esclerosis multiple y revisar los temas mas importantes del congreso ECTRIMS. En noviembre de 2017, la reunion Post-ECTRIMS celebro su decima edicion, y se ha consolidado como un importante foro de encuentro de expertos en nuestro pais para favorecer la comunicacion, establecer sinergias, y promover y potenciar la investigacion para mejorar, en ultima instancia, el pronostico y la calidad de vida de los pacientes con esclerosis multiple. En esta segunda parte se abordan las diferentes estrategias para el manejo de los pacientes con enfermedad avanzada y la seguridad de la terapia en esclerosis multiple, y se resaltan las areas que requieren una mayor evidencia cientifica y clinica. La esclerosis multiple en la poblacion pediatrica y el envejecimiento en la enfermedad cobran especial importancia en esta edicion, remarcando la necesidad del desarrollo de estudios colaborativos y de una mayor concienciacion de los especialistas en la deteccion y el manejo de las comorbilidades en la esclerosis multiple.

Publication types

  • Review

MeSH terms

  • Adult
  • Aging / physiology
  • Child
  • Clinical Trials as Topic
  • Cognition Disorders / etiology
  • Cognition Disorders / psychology
  • Cohort Studies
  • Comorbidity
  • Congresses as Topic*
  • Connectome
  • Female
  • Humans
  • Male
  • Multiple Sclerosis* / drug therapy
  • Multiple Sclerosis* / psychology
  • Neurology*
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / physiopathology